Something like a quarter of the world's population suffers from chronic pain at some point in their lives. As opposed to acute pain - for example, the feeling after hitting your finger with a hammer - chronic pain may not even have a clear cause, and it can linger for years or lifetimes. The burden of chronic pain includes damage to mental and physical health, lower productivity and drug addiction.
A new study suggests an original approach to treating this affliction, by targeting a key gateway leading to the activation of genes in the peripheral nerve cells that play a role in many forms of chronic pain. The findings of this study were published in Science.
Pain starts in the sensory neurons - those that pass information from the skin to the central nervous system. Damage to these neurons, chronic injury or disease can cause the neurons to "short circuit," sending continuous pain messages. The authors investigated molecules that regulate the biomolecular messaging activities taking place within these nerve cells. These molecules - importins - are found in every cell, acting as conduits between the cell nucleus and its cytoplasm, shuttling molecules in and out of the nucleus and thus controlling access to the genes. This role takes on special significance in the peripheral nerve cells, with their long, thin bodies in which molecular messages can take hours to get from nerve endings to cell nuclei. Some of the importins the team have identified, for example, relay messages about injury to the body of the nerve cell, initiating repair mechanisms.
To ask whether importins are involved in chronic neuropathic pain, the researchers first set out to screen a number of importin-mutant mouse lines. Behavioral screens on these different lines revealed a particular importin - importin alpha-3 - as the only importin implicated in controlling pain pathways.
The team then sought to identify the gene expression pattern associated with long-lasting pain in peripheral nerve cells, and see how it tied into importin alpha-3 activity. Analyses of differences in the expression patterns between normal neurons and neurons lacking importin alpha-3 directed attention to c-Fos, a protein that importin alpha-3 brings into the nucleus. c-Fos is a transcription factor - a molecule that raises or lowers the expression of numerous genes. Further experiments in mice showed that c-Fos accumulates in the nucleus in peripheral nerve cells of mice suffering from chronic pain.
They then used specialized viruses as tools to reduce or disable importin alpha-3 or c-Fos in mouse peripheral nerve cells. These mice had much reduced responses to chronic pain situations than those of regular mice. Further research showed that importin alpha-3 is critical in late and chronic pain. c-Fos is also involved in earlier pain responses, but it seems to enter the nucleus by other means at those earlier stages. This suggests that blocking importin alpha-3 activity might be especially well-suited to preventing lasting, chronic pain.
The research team then took their findings to the next level, asking how easily they can be translated to clinical application. They took advantage of a specialized database, the Connectivity Map (CMap) from the Broad Institute in Massachusetts, which reveals connections between drugs and gene expression patterns. This database enabled them to identify around 30 existing drugs that might target the importin alpha-3-c-Fos pathway. Almost two thirds of compounds they identified were not previously known to be associated with pain relief. The team chose two - one a cardiotonic drug and the other an antibiotic – and tested them again in mice. Indeed, injection with these compounds provides relief of neuropathic pain symptoms in mice.
"The compounds we identified in this database search are a kind of fast track - proof that drugs already approved for other uses in patients can probably be repurposed to treat chronic pain," says the author. "Clinical trials could be conducted in the near future, as these compounds have already been shown to be safe in humans."
"We are now in a position to conduct screens for new and better drug molecules that can precisely target this chain of events in the sensory neurons," says the author. "Such targeted molecules might have fewer side effects and be less addictive than current treatments, and they could provide new options for reducing the burden of chronic pain."
https://wis-wander.weizmann.ac.il/life-sciences/targeting-chronic-pain-gateway-could-bring-relief
https://science.sciencemag.org/content/369/6505/842
Nuclear transport controls chronic pain
- 1,158 views
- Added
Edited
Latest News
Targeting bone marrow adipo…
By newseditor
Posted 03 Jul
Mapping the biology of spin…
By newseditor
Posted 03 Jul
Liver biopsy to predict pan…
By newseditor
Posted 03 Jul
Significant differences in…
By newseditor
Posted 02 Jul
Serotonin 2C receptor regul…
By newseditor
Posted 02 Jul
Other Top Stories
Regulating mitochondrial fission!
Read more
How the brain tries to control blood loss
Read more
Why do we lose muscle mass when physical activity levels decline?
Read more
Brain's striatal neurons that help with decision-making
Read more
Assessing the invasive and metastatic potential of cancer cells fro…
Read more
Protocols
Monitoring norepinephrine r…
By newseditor
Posted 01 Jul
BicemuS: A new tool for neu…
By newseditor
Posted 26 Jun
Deciphering spatial domains…
By newseditor
Posted 23 Jun
High-throughput volumetric…
By newseditor
Posted 21 Jun
Bioengineered human colon o…
By newseditor
Posted 14 Jun
Publications
Targeting adipocyte ESRRA p…
By newseditor
Posted 03 Jul
Stress-induced TDP-43 nucle…
By newseditor
Posted 03 Jul
Unraveling host regulation…
By newseditor
Posted 03 Jul
Propionic acid promotes neu…
By newseditor
Posted 03 Jul
Association of genetic risk…
By newseditor
Posted 03 Jul
Presentations
Myelin plasticity in the ve…
By newseditor
Posted 10 Jun
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar